Back HIV/AIDS HIV/AIDS Topics HIV Prevention

AIDS 2016: PrEP Use Exceeds 79,000 in U.S., But Some Groups Lagging Behind

More than 79,000 people in the U.S. have started Truvada for pre-exposure prophylaxis (PrEP) over the past 4 years, according to the latest results from a survey of retail pharmacies by Gilead Sciences, presented today at the 21st International AIDS Conference (AIDS 2016) in Durban. Yet while large gains in PrEP use have been seen among men in cities with large gay communities, some groups are not benefitting as much as they could.

alt

Read more:

AIDS 2016: Researchers Now Focusing on Best Ways to Get PrEP to People Who Need It

Speaking to a pre-conference meeting on HIV pre-exposure prophylaxis (PrEP) ahead of the 21st International AIDS Conference (AIDS 2016), International AIDS Society president Chris Beyrer reminded delegates that when the International AIDS Conference was last held in Durban in the year 2000, the event was notable for drawing attention to the enormous gap in access to HIV treatment between rich and poorer countries. That conference began the treatment access era. "Now is really the time to start the PrEP access era," Beyrer said.

alt

Read more:

Retention in Care Drives Adherence in PrEP Implementation Programs

The proportion of gay and bisexual men who started and remained on Truvada for pre-exposure prophylaxis (PrEP) varied in real-world implementation programs in 3 mid-size U.S. cities, but retention in care was "consistently suboptimal," according to a study described in the June 13 online edition of the Journal of the International AIDS Society. Among those who did remain in care, however, adherence was good.

alt

Read more:

HIV Treatment Reduces HIV Transmission by 77% among South African Couples

Antiretroviral treatment reduced the risk of HIV transmission by 77% in serodiscordant couples in rural South Africa, a population-based study carried out in the province of KwaZulu-Natal has shown. The findings were recently published in the advance online edition of Clinical Infectious Diseases. The investigators say that their findings provide a real-life estimate of the impact of antiretroviral treatment on HIV transmission under normal community conditions.

alt

Read more:

Many U.S. Communities Vulnerable to HIV Outbreaks Due to Unsafe Opioid Injection

Research published recently in the online edition of the Journal of Acquired Immune Deficiency Syndromes has identified the jurisdictions in the U.S especially vulnerable to the rapid spread of HIV or hepatitis C virus (HCV) due to unsafe injection drug use. A total of 220 countries in 26 states had a high level of vulnerability, with factors associated with unsafe injecting including unemployment, and poverty, and high rates of death due to drug overdose.

alt

Read more: